FDA spars with Texas company over ‘unapproved’ and ‘unlicensed’ human amniotic products
Federal regulators have warned a Waco, Texas, company that its human amniotic products are “unlicensed” and “unapproved,” and ...
FDA raises alert on listeria-tainted broccoli sold at Walmart over risk of ‘death’
The recall affects 12-ounce bags of the product, which were sold in 20 states and pose serious health risks if consumed.
Broccoli Recall Update as FDA Sets Highest Risk Level Over Bacteria Fears
Broccoli florets sold in Walmart stores across 20 states that were recalled over bacterial contamination fears have been ...
Lay’s Classic potato chips recall elevated to highest FDA level over ‘deadly’ ingredient
The FDA first announced on December 18, 2024, that Frito-Lay issued a recall on a “limited number” of the 13 oz bags of chips ...
UT experts weigh in on FDA's ban of Red No. 3
Red No. 3 is a synthetic color additive that companies put into food, drinks and drugs to give them a bright red, cherry ...
Walmart broccoli recall elevated to highest level by FDA over risk of ‘death’
Broccoli packages sold at Walmart stores in 20 states have received an elevated recall status over a Listeria contamination ...
Abortion pill access faces new legal hurdle nationwide after Texas ruling
A Texas judge has allowed three states to move forward with a legal challenge seeking to impose stricter rules on the ...
Republican states can move ahead with abortion pill lawsuit in Texas
The Republican-led states of Idaho, Missouri and Kansas can proceed with a lawsuit seeking to restrict the availability of ...
Texas judge says states can revive challenge to abortion pill access nationwide
A federal judge in Texas is allowing three other states to pursue a challenge seeking to restrict access to the abortion pill ...
Courthouse News Service13d
New FDA tobacco warnings on pause
Tobacco companies secured interim relief from a federal court in East Texas, which enjoined the FDA from enforcing a 2020 ...
March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
Company prepares to advance to Phase 2 clinical trial in early 2025 HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- (March Bio), an emerging clinical stage biotechnology company committed to combating ...